ロード中...
The DESolve novolimus bioresorbable Scaffold: from bench to bedside
The DESolve (Elixir Medical Corporation, Sunnyvale, California, USA) is a poly-L lactide-based polymer scaffold coated with the antiproliferative and anti-inflammatory drug novolimus. The scaffold biodegrades within one year with a complete resorption in two years and in vitro bench test have shown...
保存先:
| 出版年: | J Thorac Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583086/ https://ncbi.nlm.nih.gov/pubmed/28894601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.07.25 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|